| Withdrawn | To Evaluate the Efficacy, Safety, and Tolerability of Intravenous Ganaxolone Added to Standard of Care in Refr Refractory Status Epilepticus | Phase 3 | 2024-03-01 |
| Withdrawn | Safety and Efficacy Study of IV Ganaxolone as Adjuvant Therapy for Established Status Epilepticus (ESE) Status Epilepticus | Phase 2 | 2023-04-01 |
| Terminated | Open-label Study of Adjunctive GNX Treatment in Children and Adults With TSC-related Epilepsy Tuberous Sclerosis Complex | Phase 3 | 2022-05-16 |
| Completed | Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy Tuberous Sclerosis Complex | Phase 3 | 2022-04-01 |
| Completed | Randomized Therapy In Status Epilepticus Status Epilepticus | Phase 3 | 2020-12-09 |
| Completed | Adjunctive Ganaxolone Treatment (Part A) in TSC Followed by Long-term Treatment (Part B) Tuberous Sclerosis | Phase 2 | 2020-04-08 |
| Completed | Study of Adjunctive Ganaxolone Treatment in Female Children With Protocadherin 19 (PCDH19)-Related Epilepsy (V PCDH19-Related Epilepsy | Phase 2 | 2019-05-17 |
| Completed | Study of Adjunctive Ganaxolone Treatment in Children and Young Adults With CDKL5 Deficiency Disorder CDKL5 Deficiency Disorder | Phase 3 | 2018-06-30 |
| Completed | Intravenous Ganaxolone as Adjunctive Therapy to Treat Subjects With Status Epilepticus Status Epilepticus, Convulsive Status EPILEPTICUS, Non Convulsive Status Epilepticus | Phase 2 | 2018-02-19 |
| Completed | A Clinical Trial of Oral Ganaxolone in Women With Postpartum Depression Depressive Disorder, Depression, Depression, Postpartum | Phase 2 | 2017-12-28 |
| Completed | A Clinical Trial of Intravenous (IV) Ganaxolone in Women With Postpartum Depression Depression, Depressive Disorder, Depression, Postpartum | Phase 2 | 2017-06-27 |
| Completed | Open-Label PoC Trial of Ganaxolone in Children With PCDH19 Female Pediatric Epilepsy and Other Rare Genetic Ep Epilepsy | Phase 2 | 2015-11-06 |
| Terminated | A Two-year Open-label Extension Study of Ganaxolone in Patients With Drug-resistant Partial-onset Seizures Drug Resistant Partial Onset Seizure | Phase 3 | 2015-02-01 |
| Completed | Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Ext Drug Resistant Partial Onset Seizure | Phase 3 | 2013-10-01 |
| Completed | Ganaxolone Treatment in Children With Fragile X Syndrome Fragile x Syndrome | Phase 2 | 2012-11-01 |
| Completed | Ganaxolone in Posttraumatic Stress Disorder (PTSD) PTSD | Phase 2 | 2011-04-01 |
| Completed | A Treatment Use Protocol for Subjects Continuing on From the Open-label Extension 0601 Epilepsy, Complex Partial | Phase 2 | 2009-10-01 |
| Completed | Open-label Extension to Protocol 1042-0600 Epilepsies, Partial | Phase 2 | 2007-06-01 |
| Completed | A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures Partial Epilepsy, Catamenial Epilepsy | Phase 2 | 2007-02-01 |
| Completed | A Randomized, Controlled Trial of Ganaxolone in Patients With Infantile Spasms Infantile Spasms | Phase 2 | 2007-01-01 |
| Terminated | Open-label Extension to Protocol 1042-0500 Infantile Spasms | Phase 2 | 2007-01-01 |
| No Longer Available | Ganaxolone Expanded Access Program Compassionate Use CDKL5 Disorder | — | — |